The device has evolved from one aimed at just functional MR to a broader HF therapy. EMPOWER will provide more insights.

New study shows tirzepatide reduces LV mass and heart fat in obesity-related HFpEF, potentially improving heart failure outcomes.

BACKGROUND: Circular RNAs derived from both nuclear and mitochondrial genomes are identified in animal cells.

Though learning that your child has a heart defect like a ventricular septal defect can be frightening, understanding the ...

When Matt Lewis first experienced an unusual episode of dizziness, he had no idea it was the beginning of a life-altering health battle.

The Aeson Total Artificial Heart helped three people with heart failure and pulmonary hypertension become eligible for a ...

Almost 1 million Americans are hospitalized each year for heart failure and related problems, and more than half a million are newly diagnosed annually. ChristianaCare is the only health system in the ...

The supplement tricaprin, which is found in coconut or MCT oil, improved long-term survival for people with triglyceride ...

The apparent benefits at 2 years observed in the nonrandomized ALT-FLOW study pave the way for a sham-controlled trial.

To predict arrhythmic risk in carriers of filamin C truncating variants, a novel risk predictive model was developed based on ...

The man, who was diagnosed with congestive heart failure nearly a year ago, believes the decision is based on his vaccination ...

The International Consortium for Health Outcomes Measurement (ICHOM) has developed a globally inclusive standard dataset of ...